Literature DB >> 12254

Deficiency of NADPH oxidase activity in chronic granulomatous disease.

L C McPhail, L R DeChatelet, P S Shirley, C Wilfert, R B Johnston, C E McCall.   

Abstract

NADPH oxidase activity was examined in paired 27,000 x g granule fractions isolated from normal polymorphonuclear leukocytes from patients with chronic granulomatous disease. At 0.17 mM NADPH, the oxidase activity was not measurable in normal resting cells but was activated by phagocytosis. This activation was absent in CGD cells. At higher levels of NADPH, activity was present in cells from patients with CGD, although it was lower than normal, and no difference in activity was found between resting and phagocytizing cells. Granule fractions from phagocytizing normal cells exhibited higher than granule fractions from resting normal cells at all levels of NADPH. These results suggest that NADPH oxidase activity is defective in chronic granulomatous disease, and further that the defect is not the absence of the enzyme but rather a failure to activate it.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 12254     DOI: 10.1016/s0022-3476(77)80632-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Superoxide production by digitonin-stimulated guinea pig granulocytes. The effects of N-ethyl maleimide, divalent cations; and glycolytic and mitochondrial inhibitors on the activation of the superoxide generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

3.  Allosteric transformation of reduced nicotinamide adenine dinucleotide (phosphate) oxidase induced by phagocytosis in human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; P S Shirley; L C McPhail; D B Iverson; G J Doellgast
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

4.  Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease.

Authors:  B E Seligmann; J I Gallin
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

5.  Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events.

Authors:  L C McPhail; L R DeChatelet; R B Johnston
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

6.  Protein phosphorylation of neutrophils from normal children and patients with chronic granulomatous disease.

Authors:  E Ishii; K Irita; I Fujita; K Takeshige; M Kobayashi; T Usui; K Ueda
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

Review 7.  The impact of intestinal inflammation on the nutritional environment of the gut microbiota.

Authors:  Franziska Faber; Andreas J Bäumler
Journal:  Immunol Lett       Date:  2014-05-04       Impact factor: 3.685

8.  X-linked inheritance in females with chronic granulomatous disease.

Authors:  E L Mills; K S Rholl; P G Quie
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

Review 9.  The dynamics of gut-associated microbial communities during inflammation.

Authors:  Sebastian E Winter; Christopher A Lopez; Andreas J Bäumler
Journal:  EMBO Rep       Date:  2013-03-12       Impact factor: 8.807

10.  Co-localization of superoxide generation and NADP formation in plasma membrane fractions from human neutrophils.

Authors:  P S Shirley; D A Bass; C J Lees; J W Parce; B M Waite; L R Dechatelet
Journal:  Inflammation       Date:  1984-09       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.